Actinium Pharmaceuticals, Inc (ATNM) insider trading

Every open-market stock purchase and sale by Actinium Pharmaceuticals, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • No open-market insider trades in the last 12 months.
  • Last insider buy: Sandesh Seth (CEO), $4.4K, 7 years ago.

Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales). Last close $1.60 on Oct 22, 2026.

Recent ATNM insider trades

DateInsiderTradeValue
Oct 14, 2026Matthew T David (CFO)Bought (not open market)—
Oct 14, 2026Matthew T David (CFO)Bought (not open market)—
Sep 2, 2026C. David Nicholson (Director)Bought (not open market)—
Sep 2, 2026C. David Nicholson (Director)Bought (not open market)—
Sep 2, 2026Ajit Shetty (Director)Bought (not open market)—
Sep 2, 2026Ajit Shetty (Director)Bought (not open market)—
Sep 2, 2026June Sherie Almenoff (Director)Bought (not open market)—
Sep 2, 2026June Sherie Almenoff (Director)Bought (not open market)—
Sep 2, 2026Sandesh Seth (CEO)Bought (not open market)—
Sep 2, 2026Sandesh Seth (CEO)Bought (not open market)—
Sep 2, 2026Sandesh Seth (CEO)Bought (not open market)—
Sep 2, 2026Richard I Steinhart (Director)Bought (not open market)—
Sep 2, 2026Richard I Steinhart (Director)Bought (not open market)—
Sep 2, 2026Jeffrey W. Chell (Director)Bought (not open market)—
Sep 2, 2026Jeffrey W. Chell (Director)Bought (not open market)—

Who's trading ATNM

Get free alerts when an insider at Actinium Pharmaceuticals, Inc files a new trade →